September 15, 2008 08:10 ET
EDMONTON, ALBERTA--(Marketwire - Sept. 15, 2008) - CV Technologies Inc. (TSX:CVQ) -
WHAT: News Conference to discuss results of COLD-FX's biggest trial to date.
WHO: - Dr. Gerry Predy, Principal Trial Investigator, Medical Office of Health, Alberta Health Services and Director of the Northern Alberta Vaccine Trials and Evaluation Centre. - Dr. Jacqueline Shan, President, CEO and Chief Scientific Officer, CV Technologies - Dr. Sharla Sutherland, Vice President, Clinical and Regulatory Affairs, CV Technologies
WHERE: # 1800 College Plaza, Northern Alberta Clinical Trials and Research Centre, 8215 - 112th Street, Edmonton, Alberta
WHEN: 12 noon, MT, Monday, Sept 15, 2008
CV Technologies Inc., Edmonton Research ParkWarren MichaelsVice President, Communications(780) 432-0022
See all RSS Newsfeeds